Kotak Special Opportunities Fund
The scheme seeks to generate long term capital appreciation by investing predominantly in opportunities presented by Special Situations such as Company Specific Event/Developments, Corporate Restructuring, Government Policy change and/or Regulatory changes, Technology led Disruption/ Innovation or companies going through temporary but unique challenges and other similar instances.
Growthvine rating: 3/5 — ranked #77 of 184 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹11.15 (as of 2026-10-01) |
|---|
| AUM | ₹1,479 Cr |
|---|
| Expense ratio | 1.79% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Abhishek Bisen |
|---|
| Exit load | 0.5% for redemption within 90 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −23.60% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 141.6% of Nifty 500's upside and 104.9% of its downside.
Market cap allocation
| Large cap | 11.4% |
|---|
| Mid cap | 25.5% |
|---|
| Small cap | 63.1% |
|---|
Concentration
| Top 5 holdings | 17.7% |
|---|
| Top 10 holdings | 32.9% |
|---|
| Total holdings | 40 |
|---|
Top holdings
- Triparty Repo — 5.8%
- Hero MotoCorp Limited — 3.9%
- Maruti Suzuki India Ltd. — 3.6%
- Jyoti CNC Automation Limited — 3.5%
- Marksans Pharma Ltd. — 3.3%
- PVR INOX LIMITED — 3.3%
- INDUS TOWERS LIMITED — 3.2%
- IndusInd Bank Ltd. — 3.1%
- Azad Engineering Limited — 3.0%
- POONAWALLA FINCORP LIMITED — 3.0%
Top sectors
- Industrial Products — 12.6%
- Pharma & Biotech — 12.1%
- Banking & Financial — 9.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 11.0% | Q1 (Top) | #20 of 167 |
| 2025 | 0.9% | Q3 | #88 of 132 |